Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function

Human Molecular Genetics

Volumn 10, Issue 13, 2001, Pages 1347-1357

  Paquet, Marie Eve ^a   Pece Barbara, Nadia ^a,c   Vera, Sonia ^a   Cymerman, Urszula ^a   Karabegovic, Amna ^a   Shovlin, Claire ^b   Letarte, Michelle ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DIMER; ENDOGLIN; GLYCOPROTEIN; GLYCOSYLATED PROTEIN; MONOMER; MUTANT PROTEIN; POLYPEPTIDE; PROTEIN PRECURSOR;

ADOLESCENT; ADULT; ARTICLE; CELL ACTIVATION; CELL STRAIN COS1; CELL SURFACE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; EXON; GENE CONSTRUCT; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC CODE; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; MISSENSE MUTATION; MONOCYTE; MUTANT; NEWBORN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN SECRETION; RENDU OSLER WEBER DISEASE; UMBILICAL VEIN;

EID: 0035875091     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.13.1347     Document Type: Article

References (36)

1. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line
2. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells
3. Identification and expression of two forms of the human transforming growth factor-β-binding protein endoglin with distinct cytoplasmic regions
4. Phosphorylation of the human-transforming-growth-factor-β-binding protein endoglin
5. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β
6. Biochemical characterization of the 44G4 antigen from the HOON pre-B leukemic cell line
7. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor
8. Expression cloning and characterization of the TGF-β type III receptor
9. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells
10. Endoglin is a component of the TGF-β receptor complex of human pre-B leukemic cells
11. Endoglin modulates cellular responses to TGF-β1
12. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily
13. The transforming growth factor-beta family
14. Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-β
15. Quantitation of endothelial cell specific protein E-9 employing a single monoclonal antibody in an indirect sandwich ELISA
16. Serum levels of the TGF-beta receptor are increased in atherosclerosis
17. Immunodetection and characterization of soluble CD105-TGF-β complexes
18. Endoglin, a TGF-β binding protein of endothelial cells is the gene for hereditary haemorrhagic telangiectasia type 1
19. The activin receptor-like kinase 1 gene: Genetic structure and mutations in hereditary hemorrhagic telangiectasia type 2
20. Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia tupe 1 suggest a dominant-negative effect of receptor function
21. A novel missense mutation in the endoglin gene in hereditary hemorrhagic telangiectasia
22. Mutant endoglin in Hereditary Hemorrhagic Telangectasia type I is transiently expressed intracellularly and is not a dominant negative
23. Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia
24. Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles
25. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1
26. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin
27. Two common endoglin mutations in families with hereditary hemorrhagic telangiectasia in the Netherlands Antilles: Evidence for a founder effect
28. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1
29. Expression analysis of endoglin missense and truncation mutations: Insights into protein structure and disease mechanisms
30. Endoglin-deficient mice, a unique model to study Hereditary Hemorrhagic Telangiectasia
31. Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: Issues in clinical management and review of pathogenic mechanisms
32. Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments
33. Expression of normal and truncated forms of human endoglin
34. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)
35. Activation of signalling by the activin receptor complex
36. MADR1, a MAD-related protein that functions in BMP2 signaling pathways